At Collegium Pharmaceutical, we are building a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. We have a portfolio of meaningfully differentiated medications to treat serious medical conditions, including moderate-to-severe pain and acute migraine.
The Director of National Accounts (DNA) will support the commercialization of Collegium’s products. This role will be responsible for developing and maintaining relationships with national and select regional managed care organizations and communicating the value of Collegium’s products. They will partner with internal stakeholders including Market Access &Trade, Commercial, Medical Affairs and Sales to make data-driven decisions and successfully manage pull through opportunities.
Persons applying for employment with Collegium Pharmaceutical on and after August 1, 2021, who are offered a position are expected to be able to provide proof of vaccination against COVID-19 prior to their start date as permitted under state law, unless they seek and are approved for an exemption by Collegium as a reasonable accommodation based on bona fide religious or medical grounds.